BUFFALO, NY – December 4, 2024 – A new editorial was published in Oncotarget’s Volume 15 on November 22, 2024, entitled “B7-H4: A potential therapeutic target in adenoid cystic carcinoma.” Researchers ...

Actuate Therapeutics (ACTU) announced the publication of new data in Clinical Cancer Research from a Phase II study evaluating elraglusib in ...

Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Rgenta Therapeutics Inc. has received IND clearance by the FDA for RGT-61159, which is being developed for adenoid cystic carcinoma, colorectal cancer and other solid tumors, as well as acute myeloid ...

“Proton therapy [...] seems to have decisive advantages with regard to the long-term survival of [adenoid cystic carcinoma] [...]” In general, tumors originating from the minor salivary glands often ...